The Traderszone Network

Published in TZ Latest News 2 June, 2017 by The TZ Newswire Staff

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Under the exemption, Myomo was seeking $15 million using Banq, a crowdfunding platform… Read More

read more